Hartford Financial Management Inc. Verastem, Inc. Transaction History

Hartford Financial Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$0.86 - $1.44 $3,440 - $5,760	-4,000 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$1.21 - $1.59 $6,050 - $7,950	-5,000 Reduced 55.56%	4,000 $5,000
Q1 2019 May 08, 2019	BUY	$2.79 - $4.09 $8,370 - $12,270	3,000 Added 50.0%	9,000 $27,000
Q3 2018 Nov 01, 2018	BUY	$6.86 - $9.97 $27,440 - $39,880	4,000 Added 200.0%	6,000 $44,000
Q4 2017 Jan 16, 2018	BUY	$2.99 - $4.85 $5,980 - $9,700	2,000	2,000 $6,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hartford Financial Management Inc. with notifications on news.